SHIELD THERAPEUTICS PLC ORD GBP0.015 financial statements, including revenue, expenses, profit, and loss
The total revenue of STX for the last semiannual is 6.98 M GBP, and it's 98.72% higher compared to the previous semiannual. The net income of H2 23 is -16.51 M GBP.